Effect of Mizagliflozin Repeat Dosing on Adverse Events and Postprandial Glucose Excursions
Phase 2
Active, not recruiting
- Conditions
- Postbariatric Hypoglycemia
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-02-10
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Vogenx, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT05721729
- Locations
- 🇺🇸
Stanford, Palo Alto, California, United States
🇺🇸University of Colorado / Anschutz Medical Campus, Aurora, Colorado, United States
Effect of Mizagliflozin on Postprandial Glucose and Insulin in Post-Bariatric Hypoglycemia Subjects
- First Posted Date
- 2022-09-15
- Last Posted Date
- 2024-06-25
- Lead Sponsor
- Vogenx, Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT05541939
- Locations
- 🇺🇸
Stanford, Palo Alto, California, United States
🇺🇸University of Colorado / Anschutz Medical Campus, Aurora, Colorado, United States
© Copyright 2025. All Rights Reserved by MedPath